5-Aminosalicylic acid downregulates the growth and virulence of Escherichia coli associated with IBD and colorectal cancer, and upregulates host anti-inflammatory activity

Colorectal cancer-inflammatory bowel disease nexus and felony of Escherichia coli

(2017) Abdul Arif Khan et al.   LIFE SCIENCES

A Mechanistic Model for Colibactin-Induced Genotoxicity

(2016) Alan R. Healy et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease

(2016) H. Chu et al.   SCIENCE

Gut microbiota imbalance and colorectal cancer

(2016) Johan Gagnière   WORLD JOURNAL OF GASTROENTEROLOGY

The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions

(2016) Stephen M. Vindigni et al.   Therapeutic Advances in Gastroenterology

PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation

(2015) Kyle Dammann et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Crohnʼs Disease–associated Escherichia coli Survive in Macrophages by Suppressing NFκB Signaling

(2014) Khalidur Rahman et al.   INFLAMMATORY BOWEL DISEASES

Inflammation-associated Adherent-invasive Escherichia coli Are Enriched in Pathways for Use of Propanediol and Iron and M-cell Translocation

(2014) Belgin Dogan et al.   INFLAMMATORY BOWEL DISEASES

Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer

(2014) Janelle C. Arthur et al.   Nature Communications

Colonic mucosa-associated diffusely adherentafaC+ Escherichia coliexpressinglpfAandpksare increased in inflammatory bowel disease and colon cancer

(2013) Maelle Prorok-Hamon et al.   GUT

High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer

(2013) Emmanuel Buc et al.   PLoS One

Rifaximin Resistance in Escherichia coli Associated with Inflammatory Bowel Disease Correlates with Prior Rifaximin Use, Mutations in rpoB, and Activity of Phe-Arg- -Naphthylamide-Inhibitable Efflux Pumps

(2012) V. Kothary et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

NFκB and AP-1 Drive Human Myometrial IL8 Expression

(2012) Shirin Khanjani et al.   MEDIATORS OF INFLAMMATION

Intestinal Inflammation Targets Cancer-Inducing Activity of the Microbiota

(2012) J. C. Arthur et al.   SCIENCE

NF-κB Signaling Pathway, Inflammation and Colorectal Cancer

(2010) Soly Wang et al.   Cellular & Molecular Immunology

Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells

(2010) G. Cuevas-Ramos et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression

(2009) Jaime Kaufman et al.   INFLAMMATORY BOWEL DISEASES

The Nuclear Factor NF- B Pathway in Inflammation

(2009) T. Lawrence   Cold Spring Harbor Perspectives in Biology

TNF: A master switch for inflammation to cancer

(2008) Gautam Sethi   Frontiers in Bioscience-Landmark

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: A clinical review and update

(2007) David T. Rubin et al.   INFLAMMATORY BOWEL DISEASES

Characterization of epithelial IL-8 response to inflammatory bowel disease mucosal E. coli and its inhibition by mesalamine

(2007) Sreedhar Subramanian et al.   INFLAMMATORY BOWEL DISEASES